Monday 22nd October 2018
SRUK commits to funding a pre-clinical study to evaluate a novel and innovative therapy to treat fibrosis
Skin fibrosis can be a severe and life limiting complication of scleroderma, with a dramatic impact on quality of life. It can be progressive and painful, leading to permanent ulcers and restriction of movement. Being able to limit the progression of skin fibrosis, and ultimately, reverse the effects are a key priority for SRUK and our community.